Skip to main content
. 2017 May 8;12(5):e0176661. doi: 10.1371/journal.pone.0176661

Table 2. Standardized and age-specific prevalence and weighted cumulative 4-yr incidence per 100 persons of diabetes (95% confidence interval)*.

All Male Female
Age (years) Jewish-Israelis Arab-Israelis Jewish-Israelis Arab-Israelis Jewish-Israelis Arab-Israelis
All ages
Prevalence
Incidence

10.3 (9.7,10.9)
1.8 (1.7,1.9)

18.4 (17.6, 19.1)
2.9 (2.7, 3.1)

10.7 (9.9,11.6)
2.0 (1.8,2.2)

16.7 (15.7, 17.8)
2.7 (2.5, 3.0)

9.7 (8.9,10.6)
1.6 (1.5, 1.8)

20.0 (19.0, 21.2)
3.0 (2.7, 3.2)
20–49
Prevalence
Incidence

2.7 (2.3, 3.0)
0.5 (0.4,0.6)

5.7 (5.3, 6.2)
1.1 (1.0, 1.2)

2.7 (2.3, 3.2)
0.6 (0.5, 0.7)

5.2 (4.6, 5.9)
1.1 [0.9, 1.2)

2.6 (2.1, 3.1)
0.4 (0.3,0.5)

6.2 (5.6, 7.0)
1.1 (0.9, 1.2)
50–59
Prevalence
Incidence

15.0 (13.2,16.9)
2.6 (2.2, 3.0)

32.8 (30.1, 35.8)
4.3 (3.8, 4.8)

17.6 (15.0,20.6)
2.8 (2.2,3.4)

32.9 (28.9, 37.3)
4.0 (3.2, 4.7)

12.4 (10.2,14.8)
2.4 (1.9, 2.9)

32.8 (29.0, 36.8)
4.6 (3.9, 5.4)
60 +
Prevalence
Incidence

29.8 (27.7,31.4)
4.6 (4.1, 5.0)

45.6 (43.0, 48.2)
7.1 (6.4, 7.9)

32.4 (29.3, 35.7)
5.4 (4.6, 6.1)

42.7 (39.2, 46.5)
7.3 (6.3, 8.2)

27.2 (24.5,30.2)
3.9 (3.3, 4.4)

48.3 (44.6, 52.1)
6.8 (5.8, 7.7)

Age-specific prevalence and incidence rates were calculated for 10 years intervals (e.g. 20–29, etc.) and then grouped into 3 categories according to the person’s age at the start of follow up.

*All estimates were weighted by the survey sample weight to allow for estimates to be generalizable to the overall Jewish and Arab population of Israel.